Myofascial pain syndromes, pelvic pain
Conditions
Interventions
Experiential group: 16 women with abdominal muscle pain received acupuncture ashi treatment (acupuncture technique at pain points), was applied once a week for 10 consecutive weeks by an acupuncturist
Procedure/surgery
Other
E02.190.044
Sponsors
Faculdade de Medicina de Ribeirão Preto / Universidade de São Paulo - FMRP/USP
Faculdade de Medicina de Ribeirão Preto / Universidade de São Paulo - FMRP/USP
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Women with diagnostic criteria for chronic pelvic pain secondary to abdominal myofascial syndrome; Presence of only one active trigger point on the abdominal wall, have not undergone previous treatment with topical injectable block or acupuncture, age above 18 years and premenopausal, visual analogue scale with a value above 4.4 (moderate pain)
Exclusion criteria
Exclusion criteria: Women with anticoagulation or hemorrhagic disorders, local or systemic infections; Allergy to anesthetics, acute muscle trauma, extreme fear of needles; History of complaints of chronic musculoskeletal pain such as fibromyalgia, chronic fatigue or diabetes; Aspirin intake within 3 days after injection; All patients with suspected endometriosis, interstitial cystitis, irritable bowel syndrome, or other disease that warrants or contributes to chronic pelvic pain; Endometrioma or hernia evidenced by ultrasound of the abdominal wall, infections of the abdominal wall, lack after the beginning of the treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome: decreased pain perception through the Visual Analogue Scale, Numerical Categorical Scale, McGill Pain and Algometry Questionnaire with a pressure manometer based on a significance level of 5% in pre and 1 week, 1 month , 3 months and 6 months after the interventions.;There was a reduction in the perception of pain in the participants of this study through analysis of the visual analog scale, numerical categorical scale and McGill questionnaire, and there was a correlation between these analyzed variables. At the algometry examination there was no reduction in the perception of statistically significant pain. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome: quality of life measurement using the SF-36 questionnaire and anxiety and depression risk assessment using the hospital scale of anxiety and depression (HAD), based on a 5% level of significance in the pre and 1 measurements Week, 1 month, 3 months and 6 months after the interventions.;There was no statistically significant change in the aspects related to quality of life or risk for anxiety and depression in the study participants for both groups. | — |
Countries
Brazil
Contacts
Public ContactAndréia Mitidieri
Faculdade de Medicina de Ribeirão Preto / Universidade de São Paulo - FMRP/USP
Outcome results
None listed